ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $87 | -100.0% | 34,624 | -81.4% | 0.00% | – |
| Q3 2022 | $338,000 | +317.3% | 185,910 | +626.2% | 0.00% | – |
| Q2 2022 | $81,000 | -92.8% | 25,600 | -81.9% | 0.00% | -100.0% |
| Q3 2021 | $1,132,000 | +101.1% | 141,500 | +618.3% | 0.00% | 0.0% |
| Q2 2021 | $563,000 | -74.3% | 19,700 | -73.9% | 0.00% | -66.7% |
| Q1 2021 | $2,193,000 | +192.8% | 75,500 | +20.2% | 0.00% | +200.0% |
| Q4 2020 | $749,000 | +18.3% | 62,803 | -31.6% | 0.00% | 0.0% |
| Q3 2020 | $633,000 | +170.5% | 91,800 | +143.0% | 0.00% | – |
| Q2 2020 | $234,000 | +234.3% | 37,777 | +194.8% | 0.00% | – |
| Q4 2019 | $70,000 | – | 12,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |